Doha, Qatar: In a significant contribution to Syria’s specialised health care services, Qatar Red Crescent Society (QRCS) has delivered an advanced flow cytometry machine to the Ministry of Health’s (MOH) Pathological Anatomy Laboratory in Idlib.
This is part of a project to enhance access, efficiency, and sustainability of specialized health care services in Syria, implemented in cooperation with the Syrian Arab Red Crescent Society (SARCS) and the Idlib Health Directorate.
Being the first of its kind in Syria to provide free-of-charge blood cancer diagnosis services, the machine is the most state-of-the-art in the country, used to analyse cells and diagnose and monitor blood cancers with high accuracy, helping improve chances of early detection and therapy personalization.
The flow cytometry machine is one of the main advanced medical diagnostic instruments. It is useful in diagnosing blood cancers such as leukemia and lymphoma, by identifying the type and measuring the number of cancer cells. Other uses include monitoring human immunodeficiency virus (HIV) patients, monitoring bone marrow transplants, and assessing autoimmune diseases.
According to the medical team at the Pathological Anatomy Laboratory in Idlib, this machine is a substantial upgrade to laboratory diagnostic services in the governorate.
The other two similar machines available across the country are owned by private profit-seeking hospitals. Therefore, this leading initiative by QRCS would have a great humanitarian impact, making advanced diagnosis accessible to all underprivileged patients for free.
This achievement is part of QRCS’s ongoing efforts to support the Syrian health system and secure the latest medical technologies to raise the quality of health services and ensure sustainability in serving the most vulnerable groups.
